Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FE375
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,511
Award facts
- Contract value 100% obligated
- $12,510.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency (DLA) on December 15, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. The contract carries a ceiling value of $12,510.96 with a firm fixed price structure and an ultimate completion date of December 16, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distribution will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania.
This award exemplifies AmerisourceBergen's role as a critical vendor within the DLA's Medical Supply Chain, supplying essential pharmaceutical products to support military and veteran healthcare systems. Biktarvy is an antiretroviral medication used in the treatment of HIV, demonstrating the company's provision of specialized therapeutic medications alongside its broader portfolio of generic drugs, brand-name pharmaceuticals, vaccines, and medical devices. The DLA's reliance on AmerisourceBergen through both individual delivery orders and its comprehensive prime vendor contract underscores the company's established capability to meet federal medical procurement requirements at scale and across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FE375?
SPE2DR26FE375 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FE375 worth?
The government has obligated $12,511 on SPE2DR26FE375.
Is contract SPE2DR26FE375 an order under another contract?
Yes. SPE2DR26FE375 is a delivery order under SPE2DR25D1103, an indefinite delivery contract.
Was contract SPE2DR26FE375 competed?
The extent of competition for SPE2DR26FE375 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award